A lot of studies have shown that several polymorphisms of xeroderma pigmentosum complementation group C gene (XPC), a key enzyme in the NER pathway, are associated with impaired DNA repair capacity and susceptibility to lung cancer [1], [9]–[12]. This evidence concerns the gene XPC and lung carcinoma.